Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 2
2(40.0%)
5Total
N/A(3)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02666235Phase 2Completed

Remote Ischaemic Conditioning and Coronary Endothelial Function (RIC-COR)

Role: collaborator

NCT00875732Not ApplicableCompleted

Choosing the Right Pacing Mode in Heart Failure - The CHOICE Trial

Role: collaborator

NCT02494245Not ApplicableUnknown

Increasing Physical Activity in Stroke Survivors Using STARFISH, an Interactive Mobile Phone App

Role: collaborator

NCT01846247Not ApplicableCompleted

A Very Early Rehabilitation Trial

Role: collaborator

NCT00119496Phase 2Completed

Rosiglitazone Versus Theophylline in Asthmatic Smokers

Role: collaborator

All 5 trials loaded